They got the preservation motion filed at 11:40 p.m. Claire knew the exact minute because she had watched the timestamp populate on the court's confirmation receipt while Ethan drove and she typed on her phone, both of them running on the kind of adrenaline that felt like being twenty-two again and invincible. Catherine had said it would take a judge until morning to sign, and that the filing alone would freeze anyone with sense.
"What if they don't have sense," Claire said, watching the streetlights stripe across the windshield.
"Then we have a federal spoliation claim and a judge who's already annoyed." Ethan turned onto Beacon. "Get some sleep. You've been awake for twenty hours."
"Twenty-two."
"Even better." He didn't look at her. They had agreed on no touching in the car, no reaching across, nothing that a traffic camera or a bored neighbor could catch. It made the drive feel longer, the distance between the seats deliberate and charged. She hated it and understood it completely.
Claire got four hours. At 6:14 a.m. her phone shuddered against the nightstand and she was awake before she'd decided to be, hand around the device, reading the preview before her eyes had properly focused.
BADGERGRID: 'The AI That Let a Woman Die' — internal logs show CardioSense deleted 400+ adverse event records.
She sat up. The article was already nine minutes old. By the time she'd opened it and scrolled past the photo of Mrs. Chen's hospital bed—taken at a distance, from a parking structure, or maybe bought from someone on staff—it had four thousand shares.
The logs weren't in the servers. They were in the story. Screenshots of raw database rows, the ones Ethan had spent a week trying to pull cleanly, timestamped, watermarked with internal Helix registry keys that no one outside the company should have recognized. The piece named three patient deaths besides Mrs. Chen, all of them women over sixty, all of them flagged by the algorithm as low risk in the ninety minutes before they coded. The headline used the word *died*. The body used *undetected*.
By 7:00, every local affiliate had it. By 7:30, a senator from Massachusetts had posted a statement demanding answers. By 8:00, Claire's phone was an instrument of torture, the screen lighting again and again with calls from numbers she didn't know and a few she did.
Ethan answered on the second ring and said, before hello, "I know."
"The logs—"
"I know. I've been on it since six. Claire, those aren't our screenshots." A pause. She heard him moving, a cabinet, a door. "The format is different. Ours had the header rows stripped. These have the full schema. These came from someone with direct database access."
"Mark."
"That's my first guess too."
"Can we prove it?"
"That's the problem." She heard the sound of a car starting—his car, she thought, the old sedan with the noisy ignition. "I've been calling our forensic vendor. An external breach leaves traces. An internal export from a credentialed account at three in the morning looks exactly like normal work. If it was Mark, he'd know that. He's spent fifteen years designing how we audit exactly this."
Claire stood in her kitchen in yesterday's shirt and looked at the coffeemaker without turning it on. Outside, the street was doing an ordinary Tuesday, a woman with a stroller, a delivery van double-parked. It felt obscene.
"The tipster," she said. "Whoever's been feeding Helix's motions to the press. This is their escalation."
"Or he's the same person and always was."
"You think Mark's been leaking his own company's material to control the story?"
"I think," Ethan said carefully, "a man who built a dossier on you and set a 4:30 deadline is capable of anything, and I think we're not going to guess our way to a court-admissible conclusion before the audit closes on Friday. So here's what we do. We do not accuse anyone in public. We do not confirm the logs are authentic in public. We tell Catherine, we tell the panel's counsel, and we let the FDA and the forensics people say what we can't."
"You think the FDA's going to move."
"Claire." A beat, the traffic on his end. "Look at your phone."
She looked. A push alert, one she'd muted the sound for, sat at the top of the screen.
*FDA announces emergency review of CardioSense cardiac monitoring system following report of undisclosed device failures.*
Her hand went cold around the phone. Emergency review. Not a query, not a request for information. The agency didn't use that word casually. It meant inspectors, it meant a clock, it meant the panel's Friday audit had just become a preliminary hearing for something much larger than a defect complaint.
"They're reviewing the company," she said.
"They're reviewing the *device*. Which means they'll want the underlying data. Which means the logs that just got deleted from the server are now the only copy in the world that has a chance of being admitted—and it's sitting in a news article written by someone who won't say where it came from."
Claire closed her eyes. "Dana's photos."
"Already in Catherine's hands, thank God. And the forensic copy. If the story is a fabrication, we can prove it. If the story is real, we can corroborate it with an independent chain of custody that doesn't run through BadgerGrid."
"Unless the FDA decides the leak contaminates everything."
"Unless that. Which is why we're calling Catherine right now, and why I'm on my way to your place because I am not having this conversation on a phone that anyone could be listening to."
He hung up before she could argue. She stood in the kitchen a moment longer, watching the light come up over the rowhouses, and then she went and put on coffee because there was nothing else to do with her hands.
The FDA's announcement ran all morning. It ran through her shower, through her second cup, through the calls she stopped taking and the texts she read without answering. *The agency has opened an emergency review of the CardioSense monitoring platform to assess whether the device's risk-classification algorithm systematically under-detects cardiac events in certain patient populations.* No one at Helix had released a statement. The company's communications director, a woman Claire had worked with for six years, had gone silent in a way that felt deliberate and expensive.
Ethan arrived at 8:20 with two coffees she didn't need and a legal pad.
"Catherine's already on the phone with the panel," he said, sitting at her kitchen table like he'd done it a hundred times. "The emergency review supersedes the Friday audit. It's not postponed, it's absorbed. The FDA takes the panel's findings as input."
"Is that good or bad?"
"It's *fast*. Which is good, because it means the device gets tested by someone with subpoena power and no interest in Helix's stock price. It's bad because the leak gave the company a narrative: the data was manipulated, the leaks are unreliable, everything's contaminated." He flipped the pad to a page already dense with his handwriting. "We disprove that by handing the FDA the forensic copy and Dana's incident report on the ninety-minute gap. Cleanly. No press. No leaks. Let the agency do what we can't."
"And Mark?"
"Catherine's filing a preservation demand on every account in his name, personal and corporate, at nine. If he exported those records, the metadata will show it. She's also going to request his badge logs." Ethan set the pen down. "But Claire—even if we prove he did it, we have to be careful how we use that. The man is already on administrative leave for misconduct he's still denying. If we go public with an accusation we can't support in court, we give him standing for a defamation suit and we hand Helix a reason to call everything we've built a personal vendetta."
"I know."
"So we don't say it. Not to the press, not to the panel, not to each other in any room with a microphone. We hand it to the FDA and we let them connect the dots."
She looked at him. He looked back, and his face—the same face she'd been reading for months, flat, patient, holding something back—was doing the thing that meant he was more worried than he was showing.
"What aren't you telling me," she said.
Ethan was quiet a long moment. Then: "The BadgerGrid piece says the reporter has more documents. It says the source is inside the company and still active." He tapped a finger, once, on the table. "If this isn't Mark, then we have a second problem entirely. Someone with database access is using our case to burn the company down. And they've been planning it long enough to have four hundred pages of patient records ready to publish."
Claire thought about the 5:52 a.m. text, the one that had started all of this. The six-minute head start. The way every one of their moves had been anticipated, overruled, accelerated.
They had a deadline on Friday, a federal agency at the door, and no idea who was actually holding the flashlight.
Her phone buzzed again in her hand. This time it was a number she didn't recognize, followed by a text message with no greeting and no signature.
*You're welcome.*